Eterna Therapeutics Inc.

Historical 13F Holders

Symbol
ERNA
CUSIP
114082209
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Every filing for 114082209 since 12/18/2024, newest first.

Filer % of Class Filed
Charles Cherington 13D/A Amendment 7 37.9% 6/11/2025
Event 6/9/2025
Shameek Konar 13G
5.5% 5/15/2025
Event 3/31/2025
John D. Halpern 13G/A Amendment 5
9.6% 5/15/2025
Event 3/31/2025
Iaf, LLC 13G/A Amendment 2 5.2% 5/14/2025
Event 3/31/2025
Freebird Partners LP 13G/A Amendment 4
9.9% 5/14/2025
Event 3/31/2025
Charles Cherington 13D/A Amendment 6 32.8% 4/4/2025
Event 4/2/2025
Charles Cherington 13D/A Amendment 5 32.4% 3/5/2025
Event 10/29/2024
Nicholas Jason Singer 13G/A Amendment 4
4.9% 2/14/2025
Event 12/31/2024
John D. Halpern 13G/A Amendment 4
10.0% 2/14/2025
Event 10/29/2024
Iaf, LLC 13G/A Amendment 1 5.2% 2/12/2025
Event 10/29/2024
Freebird Partners LP 13G/A Amendment 3
10.0% 1/28/2025
Event 10/29/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q1 30 1.49 M $264k
2024 Q4 27 995 k $292k
2024 Q3 23 712 k $747k
2024 Q2 21 390 k $712k
2024 Q1 24 409 k $981k
2023 Q4 21 355 k $637k
2023 Q3 23 331 k $728k
2023 Q2 21 333 k $750k
2023 Q1 22 332 k $1.14M
2022 Q4 21 330 k $1.19M